Aluminum carbonate, aluminum hydroxide, aluminum phosphate, amygdalin, cyanocobalamin, deferoxamine, dihydroxyaluminum aminoacetate, dihydroxyaluminum sodium carbonate, indinavir, magaldrate.
Ascorbic acid may increase absorption of iron in iron deficiency states.
Omeprazole may affect the bioavailability of dietary vitamin C.
Ascorbic Acid is given in addition to Deferoxamine to patients with iron overload to achieve better excretion. However, early on in treatment when there is excess tissue iron there is some evidence that ascorbic acid may worsen iron toxicity, particularly to the heart. Thus, ascorbic acid should not be given for the first month after starting Deferoxamine treatment.
Laboratory Interactions: Ascorbic acid could cause chemical interference in laboratory tests for blood or urine creatinine, glucose and uric acid.
Other Services
Country
Account